OKYO Pharma has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 80,000 of the Company’s ordinary shares on NASDAQ at a price of $1.15 per share. This brings the total shareholding of Mr Cerrone to 9,801,570 shares which is 28.97% of issued share capital.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKYO:
- OKYO Pharma Secures U.S. Patent for DED Therapy
- Okyo granted U.S. patent covering OK-101’s for DED treatment
- OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
- OKYO Pharma Advances in Ocular Disease Therapies
- OKYO Pharma CEO Interview to Air on Bloomberg TV